Cargando…

A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics

Idiopathic intracranial hypertension (IIH) is a condition of unknown etiology, characterized by elevated intracranial pressure frequently manifesting with chronic headaches and visual loss. Similar to polycystic ovary syndrome (PCOS), IIH predominantly affects obese women of reproductive age. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Reilly, Michael W., Westgate, Connar S.J., Hornby, Catherine, Botfield, Hannah, Taylor, Angela E., Markey, Keira, Mitchell, James L., Scotton, William J., Mollan, Susan P., Yiangou, Andreas, Jenkinson, Carl, Gilligan, Lorna C., Sherlock, Mark, Gibney, James, Tomlinson, Jeremy W., Lavery, Gareth G., Hodson, David J., Arlt, Wiebke, Sinclair, Alexandra J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483000/ https://www.ncbi.nlm.nih.gov/pubmed/30753168 http://dx.doi.org/10.1172/jci.insight.125348

Ejemplares similares

11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial
por: Markey, Keira, et al.
Publicado: (2020)

11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension
por: Hardy, Rowan S, et al.
Publicado: (2020)

Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
por: Westgate, Connar S J, et al.
Publicado: (2022)

Evaluating the Fat Distribution in Idiopathic Intracranial Hypertension Using Dual-Energy X-ray Absorptiometry Scanning
por: Hornby, Catherine, et al.
Publicado: (2017)

Topiramate is more effective than acetazolamide at lowering intracranial pressure
por: Scotton, William J, et al.
Publicado: (2018)

Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain?
por: Yiangou, Andreas, et al.
Publicado: (2018)

Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension
por: Westgate, Connar S.J., et al.
Publicado: (2021)

Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online survey
por: Scotton, William J, et al.
Publicado: (2018)

Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention
por: Hornby, Catherine, et al.
Publicado: (2018)

What Do Transgender Patients Teach Us About Idiopathic Intracranial Hypertension?
por: Hornby, Catherine, et al.
Publicado: (2017)

Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fibre layer thickness in idiopathic intracranial hypertension
por: Aojula, Anuriti, et al.
Publicado: (2018)

MON-203 Local Activation of 11-Oxygenated Androgens by AKR1C3 Is the Predominant Source of Androgens in Human Female Adipose Tissue
por: Schiffer, Lina, et al.
Publicado: (2019)

Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial
por: Mollan, Susan P., et al.
Publicado: (2021)

Evaluation and management of adult idiopathic intracranial hypertension
por: Mollan, Susan P, et al.
Publicado: (2018)

Headache determines quality of life in idiopathic intracranial hypertension
por: Mulla, Yasmeen, et al.
Publicado: (2015)

A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension
por: Mollan, Susan P, et al.
Publicado: (2014)

Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
por: Grech, Olivia, et al.
Publicado: (2021)

Association of Amount of Weight Lost After Bariatric Surgery With Intracranial Pressure in Women With Idiopathic Intracranial Hypertension
por: Mollan, Susan P., et al.
Publicado: (2022)

Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension
por: Yiangou, Andreas, et al.
Publicado: (2020)

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)

The Regulation of Steroid Action by Sulfation and Desulfation
por: Mueller, Jonathan W., et al.
Publicado: (2015)

Nuclear Magnetic Resonance Spectroscopy Metabolomics in Idiopathic Intracranial Hypertension to Identify Markers of Disease and Headache
por: Grech, Olivia, et al.
Publicado: (2022)

Acute Hypercortisolemia Exerts Depot-Specific Effects on Abdominal and Femoral Adipose Tissue Function
por: Manolopoulos, Konstantinos N., et al.
Publicado: (2017)

Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)
por: Yiangou, Andreas, et al.
Publicado: (2021)

Multiple lumbar punctures aiming to relieve headache results in iatrogenic spinal hematoma: a case report
por: Lyons, Hannah S., et al.
Publicado: (2022)

Idiopathic intracranial hypertension, hormones, and 11β-hydroxysteroid dehydrogenases
por: Markey, Keira A, et al.
Publicado: (2016)

Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management
por: Mollan, Susan P, et al.
Publicado: (2016)

Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy
por: Dineen, Rosemary A, et al.
Publicado: (2023)

Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
por: Mollan, S. P., et al.
Publicado: (2021)

Preclinical update on regulation of intracranial pressure in relation to idiopathic intracranial hypertension
por: Eftekhari, Sajedeh, et al.
Publicado: (2019)

Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol
por: Ottridge, Ryan, et al.
Publicado: (2017)

Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension
por: Westgate, Connar Stanley James, et al.
Publicado: (2021)

Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom
por: Adderley, Nicola J., et al.
Publicado: (2019)

11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
por: O’Reilly, Michael W., et al.
Publicado: (2016)

A Prospective Cross-Over Study of Tissue Glucocorticoid Metabolism in Patients With Adrenal Insufficiency: The Effects of Dual-Release Hydrocortisone Therapy
por: Dineen, Rosemary Anne, et al.
Publicado: (2021)

Long-term monitoring of intracranial pressure in freely-moving rats; impact of different physiological states
por: Eftekhari, Sajedeh, et al.
Publicado: (2020)

Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial
por: Markey, Keira Annie, et al.
Publicado: (2017)

The Health Economic Evaluation of Bariatric Surgery Versus a Community Weight Management Intervention Analysis from the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT)
por: Aguiar, Magda, et al.
Publicado: (2021)

Alterations in metabolic flux in migraine and the translational relevance
por: Grech, Olivia, et al.
Publicado: (2022)

Glucocorticoids modify intracranial pressure in freely moving rats
por: Westgate, Connar Stanley James, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_joqisj9deudvrligd07udqftoq